Chet Wiener

Chet Wiener has diverse work experience in the field of medical writing. They currently hold the position of Associate Director, Medical Writing at Nektar Therapeutics since January 2022. Prior to this, they worked as a Senior Manager, Medical Writing at Nektar Therapeutics from May 2016 to January 2022. Chet also worked at Edison Pharmaceuticals as a Medical Writer from November 2014 to April 2016. They held the role of Senior Manager, Medical Writing at Exelixis from an undisclosed date to November 2014. Before their corporate roles, Chet served as the Principal at Chet Wiener PhD, Medical Writing, Editing, and Translation from 2005 to 2011. In this position, they worked on a wide range of projects, including Clinical Study Reports for oncology compounds, Clinical Evaluation Reports for devices, Protocols, Clinical Study Reports, and Investigator's Brochure for insulin oral spray and delivery system.

Chet Wiener has an extensive education history. Chet began their academic journey in 1979 at The Johns Hopkins University, where they completed their Bachelor of Arts degree in an unspecified field of study in 1983. Following this, they pursued a Master of Arts degree at the University of Chicago, completing the program in 1985. Chet went on to enroll at the University of Iowa in 1987, where they obtained their Master of Fine Arts degree in the following year. Chet continued their education by undertaking a Ph.D. program at Columbia University, which they successfully completed in 1998. The specific field of study for their Ph.D. remains unknown.